Ionis Pharmaceuticals IONS Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's change in AP?
- Ionis Pharmaceuticals (IONS) reported change in AP of -$3.1M in Q1 2026.
- How has Ionis Pharmaceuticals's change in AP changed year-over-year?
- Ionis Pharmaceuticals's change in AP increased by 88.1% year-over-year, from -$25.97M to -$3.1M.
- What does change in AP mean?
- The net change in money owed to suppliers for goods and services.
- How do you interpret change in AP?
- An increase improves cash flow by delaying cash outflows, while a decrease indicates faster payment to vendors.
- How does change in AP compare across companies?
- Standard working capital metric; peers with strong bargaining power often maintain higher payable levels to optimize cash.